Genetic imaging study with [Tc-(99m)] TRODAT-1 SPECT in adolescents with ADHD using OROS-methylphenidate


AKAY A., ÇAPA KAYA G., Kose S., ERESEN YAZICIOĞLU Ç., Erkuran H. O., ALŞEN GÜNEY S., ...Daha Fazla

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, cilt.86, ss.294-300, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 86
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.pnpbp.2018.04.008
  • Dergi Adı: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.294-300
  • Anahtar Kelimeler: ADHD, DAT1 gene, [Tc-(99m)] TRODAT-1 SPECT, OROS-methylphenidate, DEFICIT HYPERACTIVITY DISORDER, DOPAMINE-TRANSPORTER GENE, ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, TC-99M-TRODAT-1 SPECT, PARKINSONS-DISEASE, CHILDREN, ASSOCIATION, ADULTS, PSYCHOSTIMULANTS, AVAILABILITY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Aim: To examine theeffects on the brain of 2-month treatment withamethylphenidate extended-release formulation (OROS-MPH) using [Tc-(99m)] TRODAT-1SPECT in a sample of treatment-naive adolescents with Attention Deficit/Hyperactivity Disorder (ADHD). In addition, to assess whether risk alleles (homozygosity for 10-repeat allele at the DAT1 gene were associated with alterations in striatal DAT availability.